China trade mission a bridge-mending opportunity for GSK?
This article was originally published in Scrip
Executive Summary
Sir Andrew Witty may be among the prominent members of British Prime Minister David Cameron's huge trade mission to China this week, but it is not clear if or how the delegation and the GlaxoSmithKline CEO's presence may affect the ongoing corruption probe into the company in the country.